News
Innovation Magazine Summer 2024 Edition
In this issue:
- A new partnership with UCLA Ventures
- Funding updates for TORL, Pelage Pharmaceuticals, UCLA Samueli, and ImmPACT Bio
- A trip to the UCLA Research Park
- Event wrap ups for MedTech, LABEST and UCLA Ventures dinner
and more
Biden administration proposal threatens innovative research
Biden administration proposal threatens innovative research at universities across the country
![](/sites/default/files/inline-images/TDB-L-UCLA-PVSITE-0928-02.jpeg)
UCLA students transition between classes at the Westwood campus on September 27, 2022. (Photo by Dean Musgrove, Los Angeles Daily News/SCNG)
CrewLAB Raises $1.6M to Democratize Data & Technology for Endurance Sports Teams
CrewLAB Raises $1.6M to Democratize Data & Technology for Endurance Sports Teams
GV Backs Hair Loss Biotech out of UCLA with PhII set for mid-2024
![](/sites/default/files/inline-images/GV%20Backs%20PhII%20Hair%20Loss%20Photo%20.jpg)
Pelage Pharmaceuticals, a Los Angeles-based hair loss biotech based on research out of UCLA, has reeled in a $16.75 million Series A and plans to start a mid-stage trial later this year.
See full article below;
Immpact Bio Awarded $8million CIRM Grant
![](/sites/default/files/inline-images/Immpact%20Bio%20Logo.jpg)
![](/sites/default/files/inline-images/Immpact%20Bio%20Headline%20Bloc.jpg)
Please see full article on PR News below:
LABEST 2024 Early Bird On Sale Now
Early Bird Tickets to LABEST 2024 are now available.
The Lancet Neurology features UCLA researcher Rhonda Voskuhl
UCLA Researcher Rhonda Voskuhl featured in neurology journal
![Rhonda Voskuhl image](/sites/default/files/inline-images/Rhonda%20in%20Lab_0.jpeg)
![Lancet Neurology image](/sites/default/files/inline-images/Screenshot%202024-02-06%20at%2011.24.08%E2%80%AFAM_0.png)
UCLA TDG Innovation Magazine Winter 2023
UCLA TDG Innovation Magazine Winter 2023 Highlights
* UCLA TDG by the Numbers
* UCLA Ranks #1 in Scientific Publications in the LA Region
* Equatic named one of TIME Magazine's Best Inventions of 2023
* FDA Fast Track for ImmPact Bio therapeutic
* Autobahn and UCLA
and more